Ani Pharmaceuticals Inc SEC filings ANIP
Ani Pharmaceuticals Inc has 1,002 filings in SEC EDGAR's recent list, going back to Nov 3, 2014. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| 4 | Insider transaction | Oct 30, 2026 | Oct 29, 2026 |
| 144 | Notice of proposed sale | Oct 29, 2026 | — |
| 4 | Insider transaction | Oct 16, 2026 | Oct 15, 2026 |
| 144 | Notice of proposed sale | Oct 15, 2026 | — |
| 4 | Insider transaction | Oct 13, 2026 | Oct 13, 2026 |
| 4 | Insider transaction | Sep 30, 2026 | Sep 29, 2026 |
| 4 | Insider transaction | Sep 16, 2026 | Sep 15, 2026 |
| 144 | Notice of proposed sale | Sep 15, 2026 | — |
| 4 | Insider transaction | Sep 14, 2026 | Sep 11, 2026 |
| 4 | Insider transaction | Sep 14, 2026 | Sep 14, 2026 |
| 144 | Notice of proposed sale | Sep 11, 2026 | — |
| 4 | Insider transaction | Sep 1, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Aug 27, 2026 | Aug 19, 2026 |
| 3 | Initial insider ownership | Aug 27, 2026 | Aug 19, 2026 |
| 4 | Insider transaction | Aug 26, 2026 | Aug 25, 2026 |
| 144 | Notice of proposed sale | Aug 25, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Aug 24, 2026 | Aug 19, 2026 |
| 4 | Insider transaction | Aug 13, 2026 | Aug 13, 2026 |
| 4 | Insider transaction | Aug 11, 2026 | Aug 10, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2026 | Aug 7, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 29, 2026 |
| 144 | Notice of proposed sale | Jul 29, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 27, 2026 | — |
| 4 | Insider transaction | Jul 21, 2026 | Jul 18, 2026 |
| S-8 | Employee stock plan registration | Jul 17, 2026 | — |
| 4 | Insider transaction | Jul 14, 2026 | Jul 13, 2026 |
| 144 | Notice of proposed sale | Jul 7, 2026 | — |
| 4 | Insider transaction | Jul 6, 2026 | Jul 2, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | May 21, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | May 21, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | May 21, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | May 21, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | May 21, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 144 | Notice of proposed sale | Jun 8, 2026 | — |
| 144 | Notice of proposed sale | Jun 5, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 21, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 13, 2026 | May 11, 2026 |
| 4 | Insider transaction | May 13, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 13, 2026 | May 11, 2026 |
| 4 | Insider transaction | May 13, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 13, 2026 | May 13, 2026 |
| 144 | Notice of proposed sale | May 13, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 13, 2026 | May 13, 2026 |
| 144 | Notice of proposed sale | May 11, 2026 | — |
| 144 | Notice of proposed sale | May 11, 2026 | — |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 8, 2026 | May 8, 2026 |
| 4 | Insider transaction | Apr 13, 2026 | Apr 13, 2026 |
| ARS | Annual report to shareholders | Apr 9, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 9, 2026 | — |
| DEF 14A | Proxy statement | Apr 9, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Auditor change
|
Apr 7, 2026 | Apr 1, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 4 | Insider transaction | Mar 13, 2026 | Mar 11, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 13, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 13, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 6, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 7, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 7, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 6, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 7, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 5, 2026 |
| 144 | Notice of proposed sale | Mar 5, 2026 | — |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 3, 2026 |
| 144 | Notice of proposed sale | Mar 3, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 3, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 10-K | Annual report | Feb 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Jan 14, 2026 | Jan 13, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Dec 19, 2025 | Dec 18, 2025 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 9, 2025 | Dec 5, 2025 |
| 144 | Notice of proposed sale | Dec 9, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 1, 2025 | Nov 24, 2025 |
| 4 | Insider transaction | Nov 17, 2025 | Nov 13, 2025 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 12, 2025 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 13, 2025 |
| 144 | Notice of proposed sale | Nov 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 13, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2025 | Nov 7, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 17, 2025 | — |
| 4 | Insider transaction | Oct 14, 2025 | Oct 13, 2025 |
| 8-K |
Current report
Unregistered share sale, Change to shareholder rights
|
Sep 26, 2025 | Sep 26, 2025 |
| 4 | Insider transaction | Sep 22, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 15, 2025 | Sep 12, 2025 |
| 4 | Insider transaction | Sep 15, 2025 | Sep 12, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Sep 8, 2025 | Sep 8, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 3, 2025 |
| 144 | Notice of proposed sale | Sep 3, 2025 | — |
| 4 | Insider transaction | Aug 26, 2025 | Aug 25, 2025 |
| 144 | Notice of proposed sale | Aug 25, 2025 | — |
| 4 | Insider transaction | Aug 25, 2025 | Aug 22, 2025 |
| 4 | Insider transaction | Aug 22, 2025 | Aug 20, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 22, 2025 | — |
| 144 | Notice of proposed sale | Aug 21, 2025 | — |
| 144 | Notice of proposed sale | Aug 20, 2025 | — |
| 4 | Insider transaction | Aug 20, 2025 | Aug 18, 2025 |
| 4 | Insider transaction | Aug 20, 2025 | Aug 20, 2025 |
| 144 | Notice of proposed sale | Aug 20, 2025 | — |
| 144 | Notice of proposed sale | Aug 19, 2025 | — |
| 4 | Insider transaction | Aug 18, 2025 | Aug 18, 2025 |
| 4 | Insider transaction | Aug 18, 2025 | Aug 15, 2025 |
| 4 | Insider transaction | Aug 18, 2025 | Aug 14, 2025 |
| 4 | Insider transaction | Aug 18, 2025 | Aug 15, 2025 |
| 144 | Notice of proposed sale | Aug 18, 2025 | — |
| 144 | Notice of proposed sale | Aug 18, 2025 | — |
| 144 | Notice of proposed sale | Aug 18, 2025 | — |
| 144 | Notice of proposed sale | Aug 15, 2025 | — |
| 144 | Notice of proposed sale | Aug 15, 2025 | — |
| 144 | Notice of proposed sale | Aug 15, 2025 | — |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Aug 14, 2025 | Aug 13, 2025 |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 144 | Notice of proposed sale | Aug 14, 2025 | — |
| 144 | Notice of proposed sale | Aug 12, 2025 | — |
| 144 | Notice of proposed sale | Aug 12, 2025 | — |
| 144 | Notice of proposed sale | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Other events
|
Jul 29, 2025 | Jul 29, 2025 |
| 8-K |
Current report
Other events
|
Jul 23, 2025 | Jul 23, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jul 23, 2025 | Jul 23, 2025 |
| 4 | Insider transaction | Jul 21, 2025 | Jul 18, 2025 |
| 4 | Insider transaction | Jul 14, 2025 | Jul 14, 2025 |
| S-8 | Employee stock plan registration | Jul 11, 2025 | — |
| S-8 | Employee stock plan registration | Jul 11, 2025 | — |
| 4 | Insider transaction | Jun 16, 2025 | Jun 13, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 4, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jun 4, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 22, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
May 23, 2025 | May 22, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 20, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 15, 2025 | May 14, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 144 | Notice of proposed sale | May 12, 2025 | — |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 9, 2025 | May 9, 2025 |
| DEFA14A | Additional proxy material | May 8, 2025 | — |
| 8-K |
Current report
Other events
|
May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | Apr 14, 2025 | Apr 14, 2025 |
| ARS | Annual report to shareholders | Apr 10, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| DEF 14A | Proxy statement | Apr 10, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 10, 2025 | — |
| PRE 14A | Preliminary proxy statement | Mar 31, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Mar 25, 2025 | Mar 23, 2025 |
| 4 | Insider transaction | Mar 25, 2025 | Mar 23, 2025 |
| 4 | Insider transaction | Mar 20, 2025 | Mar 19, 2025 |
| 8-K |
Current report
Other events
|
Mar 18, 2025 | Mar 18, 2025 |
| 4 | Insider transaction | Mar 14, 2025 | Mar 13, 2025 |
| 4 | Insider transaction | Mar 14, 2025 | Mar 7, 2025 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANIP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Princeton, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1023024
- Former names
- BIOSANTE PHARMACEUTICALS INC (until Jul 18, 2013); BEN ABRAHAM TECHNOLOGIES INC (until Dec 23, 1999)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.